News Numinus expands psychedelics research operations in Arizona This will be the company's fifth research clinic in the United States Natalia Buendia CalvilloFebruary 17, 2023
Psychedelics PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes Natalia Buendia CalvilloFebruary 14, 2023
Psychedelics Psyched Wellness formulates first commercial Amanita muscaria extract The cartoon-like toadstool is psychoactive, has medicinal properties and lives in a symbiotic relationship with certain trees Rowan DunneFebruary 9, 2023
Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
News Australia re-classifies MDMA and psilocybin to be prescribed as medicine Psychiatrists can now prescribe MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression Natalia Buendia CalvilloFebruary 3, 2023
Psychedelics Woke Pharma and Swinburne U partner for Australia’s biggest psilocybin trial The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression Rowan DunneFebruary 1, 2023
Psychedelics Calgary’s ATMA launches psychedelic-assisted therapy training course for physicians The program's creation was inspired by new regulations for psychedelic-assisted therapy in Alberta Rowan DunneJanuary 27, 2023
Psychedelics PharmAla Biotech gets Health Canada approval to export large MDMA shipment to the U.K. The company believes this to be the largest shipment of MDMA the government department has ever approved Rowan DunneJanuary 24, 2023
Psychedelics Apex Labs doses first patient in Veterans take-home psilocybin drug trial The development marks a 'watershed moment for psilocybin research' says the company's CEO Rowan DunneJanuary 18, 2023
Psychedelics New York legislators introduce bill to legalize natural psychedelics Bill A00114 would legalize adult possession and use of ibogaine, mescaline, psilocybin and psilocin Natalia Buendia CalvilloJanuary 3, 2023